Weaponized Safety: How the FDA Is Killing mRNA
The FDA's refusal to review Moderna's flu vaccine isn't about safety. It is about a retroactive change in math that protects incumbents and drives innovation offshore.
1 article
The FDA's refusal to review Moderna's flu vaccine isn't about safety. It is about a retroactive change in math that protects incumbents and drives innovation offshore.